Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.